Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Clinical trial NCT00376584 · COMPLETED

Trial details

NCT number: NCT00376584
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesteremia Hyperlipidemia

Start date: 2006-07-01
Primary completion: 2007-01-01
Enrollment: 825

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.